Research Grant Program supports investigators studying Prader-Willi and Schaaf-Yang syndromes through basic, translational, and clinical research to deepen understanding and advance meaningful treatments.
Funder: Foundation for Prader-Willi Research
Due Dates: September 4, 2026 (Fall LOI) | November 13, 2026 (Fall proposal) | February 26, 2027 (Spring LOI) | May 14, 2027 (Spring proposal)
Funding Amounts: Up to $150,000 USD in direct costs for 18 months, plus up to 8% indirect costs; competitive 18-month renewal available
Summary: Supports innovative basic, translational, and clinical research advancing understanding and treatments for Prader-Willi and Schaaf-Yang syndromes.
Key Information: Principal investigators must hold a primary faculty appointment at Instructor level or higher.
The Foundation for Prader-Willi Research (FPWR) supports high-impact research on Prader-Willi syndrome (PWS) and Schaaf-Yang syndrome (SYS) through two competitive grant cycles each year. The program funds basic, translational, and clinical research from investigators worldwide, prioritizing innovative, high-risk/high-reward projects with potential to improve lives and accelerate meaningful treatments.
FPWR welcomes early-career investigators, established researchers entering the field, pilot and proof-of-concept studies, and collaborative therapeutic research. Priorities span genetics, hunger and metabolism, cognition and mental health, clinical care, and novel or repurposed treatments. All scientifically meritorious PWS/SYS research will be considered, including shared research resources and models. Highly integrated, multidisciplinary teams addressing ambitious questions beyond the scope of one or two investigators are encouraged.